Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells.

Previous studies have demonstrated that bispecific hybrid antibodies produced by cell-cell fusion or chemically conjugated heteroaggregates can direct cytotoxic T lymphocytes to kill target cells for which they have no intrinsic specificity, a phenomenon we call effector cell retargeting (ECR). Thes...

Description complète

Détails bibliographiques
Auteurs principaux: Gilliland, L, Clark, MR, Waldmann, H
Format: Journal article
Langue:English
Publié: 1988